A lengthy report published by the Associated Press on Thursday focused on the Sacklers, the family behind Purdue Pharma, the Stamford-based maker of OxyContin.

The Sackler family owns Purdue Pharma, which filed for bankruptcy this week as part of an effort to settle the roughly 2,600 lawsuit filed against the company, accusing it of being a catalyst in the national opioid crisis. Over the last 20 years, more than 400,000 people in the United States have died as a result of the crisis.

The family have not often spoken publicly in recent years. And, earlier this wee, did not show up to the company’s first bankruptcy hearing in White Plains, N.Y.

The Associated Press reported that Raymond, Mortimer and Arthur Sackler — who were all doctors — bought the drug company in 1952 when it was known as Purdue Frederick. The three brothers have since died. Now, their widows, children and grandchildren own Purdue and an international drug company called Mundipharma.

Purdue is privately held. Its board has been mostly controlled by the Sackler heirs over the years until legal issues started to pile up over the last year. Currently, no Sackler family member holds a seat on the board.

In court filings, attorneys for members of the Sackler clan have said their clients — who serve as company directors — were not heavily involved in the day-to-day decisions at the company.

FAMILY MONEY

Forbes magazine listed the Sacklers as one of the 20 wealthiest families in the United States back in 2016. Forbes estimated the family’s holdings at $13 billion.

For decades, Sackler family members have been major philanthropic donors.

In the 1970s, the Sacklers underwrote the Metropolitan Museum of Art wing that houses an ancient Egyptian temple. The wing bears the Sackler name.

But in 2019, places including the Met, Britain’s Tate museums, New York’s Guggenheim and Tufts University — where the graduate school of biomedical sciences also bears the family’s name — have stated they intend to stop accepting gifts from the family or plan to re-evaluate the standing of their relationship with the Sacklers.

In Paris, the Louvre Museum took the Sackler name off a wing.

Over the last 12 years, according to legal filings, states have contended the heirs of Mortimer and Raymond Sackler have taken payments totaling at least $4 billion.

RAYMOND SACKLER

Raymond Sackler’s son Richard was an executive at Purdue Pharma when OxyContin launched in 1996. Richard Sackler, who now lives in Florida, later became CEO of Purdue.

Plaintiffs in the lawsuits have latched onto Richard Sackler’s words — specifically his remarks to the company sales force at a 1996 launch party for OxyContin. At the party, held shortly after a major snowstorm, he said the launch of OxyContin would “be followed by a blizzard of prescriptions that will bury the competition. The prescription blizzard will be so deep, dense and white.”

State and local governments now suing Purdue maintain that marketing by Purdue opened the door to wider use of prescription opioids.

In a 1999 email cited in court filings, Richard Sackler wrote, “You won’t believe how committed I am to make OxyContin a huge success. It is almost that I dedicated my life to it.”

During a 2015 deposition, Richard Sackler estimated his family had made more than $1 billion but less than $10 billion. When he was asked whether he felt OxyContin was marketed too aggressively during that 2015 deposition, the Associated Press reported, he gave a one-word answer: “no.”

MORTIMER SACKLER

Mortimer Sackler lived in London at the time of his death. His widow, Thersa, who lives in England, and children (Mortimer D.A. Sackler, Kathe Sackler and Ilene Sackler Lefcourt) are all former board members and named in lawsuits.

Two of Mortimer Sackler’s kids, Mortimer D.A. Sackler and Kathe Sackler, were also Purdue executives.

Kathe Sackler was asked about an email linked to her in an April 1 deposition.

That email included the lines: “I will strenuously protest approval of any document that suggests or implies, as this draft does, that Richard Sackler was responsible for the idea of developing a controlled-release oxycodone product. As you know, when I told Richard of my idea in the mid ’80s, he asked me what oxycodone was.”

When she was questioned under oath, Kathe Sackler said she didn’t remember writing the email and that it would have been “uncharacteristic” for her to have written it, the Associated Press reported.

ARTHUR SACKLER

Separate from his familial attachment to Purdue, Arthur Sackler worked in advertising and designed campaigns aimed at doctors for drugs such as Valium.

In 1997, Arthur Sackler was posthumously inducted into the Medical Advertising Hall of Fame. A citation about him says he “helped shape pharmaceutical promotion as we know it today.”

Arthur Sackler died years before OxyContin hit the market, leading states that have filed lawsuits against members of the family not to name his heirs.

YOUNGER GENERATION

But some members of the younger generations of Sacklers have accepted media interviews and briefly addressed their connections with the drug company.

Richard Sackler’s son David and David’s wife, Joss, gave interview for magazine profiles published earlier this year, breaking some of that silence from the Sackler clan when it comes to speaking publicly.

David Sackler surfaced in headlines in 2018 when it was reported he paid $22.5 million in cash for a Los Angeles mansion. He told Vanity Fair his family has been vilified because they have not publicly told their story.

Joss Sackler, in a Town & Country interview, voiced frustration with media attention on her connection to the Sacklers instead of focusing on her work. She has a doctorate in linguistics, is a rock climbing guide and has her own fashion line.

The spotlight was pointed back at Joss Sackler’s connection to the Sacklers in a recent Instagram post by rock star Courtney Love. In the post, directed at Joss Sackler, Love wrote, “Your. People. Killed. My. People.”

The Associated Press contributed to this report.